PN6047; a potent and. selective delta opioid receptor agonist, effective against chronic pain

Size: px
Start display at page:

Download "PN6047; a potent and. selective delta opioid receptor agonist, effective against chronic pain"

Transcription

1 PN6047; a potent and selective delta opioid receptor agonist, effective against chronic pain

2 Therapeutic target Chronic pain varies from mild discomfort to the worst pain imaginable. In the UK, the total cost of chronic pain is estimated at around 10 billion per year with about 20% attributed to neuropathic pain; osteoarthritis treatment costs about 128 million per annum. Incidence is high and is increasing with aging populations. Why target delta (δ) opioid receptors for treating chronic pain? 2

3 Location of δ-opioid receptors (DOR) in pain pathway Perception of pain; control of emotion Modulation of pain signals Transmission of pain signals Generation of pain signals DORs are located at key points in the pathway to reduce pain, especially when it becomes chronic

4 Other reasons for targeting delta opioid receptors for treating chronic pain? Existing therapies (opioids, antidepressants, Na + channel blockers) only partly effective in neuropathic pain, OA etc. Strong opioids (morphine-like) work well in acute pain but are non-selective for all opioid receptors (μ, δ, κ). Side effects ; nausea, respiratory depression, itching, constipation largely due to μ receptor activation. Analgesic tolerance can be detected within hrs of morphine administration.

5 DOR knockout mice show only subtle modification of acute pain thresholds but display increased neuropathic and inflammatory pain. Therefore, DORs should be effective in these conditions. Original DOR agonists showed few signs of unwanted side effects (constipation, respiratory depression) in pre-clinical testing. Why develop biased DOR agonists?

6 What is agonist bias? DOR agonist Conventionally, thought that all receptor agonists could activate whole spectrum of possible signalling pathways ; now clear that different agonists induce particular receptor conformations leading to distinct signalling outcomes; some beneficial some not. This is agonist bias.

7 PharmNovo has developed a series of compounds showing a range of agonist effects on different signalling systems. PN6047 is a full agonist regarding camp inhibition but partial regarding β-arrestin recruitment and DOR internalization. This is a combination of properties that we believe to be optimal for clinical effects.

8 PN6047 In vivo analgesia Analgesic effect of PN6047 in rat model of neuropathic pain PN6047 is potent (half maximal effect at ~ 1 mg/kg oral). PN6047 is very selective; selectivity at delta receptors >20,000- fold (δ vs μ). In comparison, morphine is 50-fold selective for μ vs δ.

9 % c o n tr o l h y p e r s e n s itiv ity PN6047 P N (3 m g /k g, p.o.) r e d u c tio n in m e c h a n ic a l h y p e r a lg e s ia in n e u r o p a th ic m o u s e m o d e l In vivo analgesia P N C o n tro l T im e o f tr e a tm e n t (d a y s ) Marked tolerance is a property of non-selective opioids. No development of tolerance to the analgesic effects of PN6047 over 3 weeks of repeated daily treatment in a mouse sciatic nerve ligation model of neuropathic pain.

10 Statistical analysis, unpaired t-test using Prism A major negative property of early DOR agonists was proconvulsant activity. In doses up to 20 mg/kg, PN6047 produced no seizures and did not change the seizure response to pentylenetetrazole (PTZ) in mice. Dose (mg/kg) PTZ induced seizures - Myoclonus Vehicle (n=12) PN6047 (n=11)

11 Non-selective opioids cause problematic constipation; in rats and mice PN6047 does not. No changes in body weight on repeated treatment. No behavioural changes. Conclusion; PN6047 is well tolerated in animal tests and produces no toxic effects, with safety dosing based on 50 times the therapeutic dose. Prediction of human ADME/PK-properties is favourable - moderate oral bioavailability, t1/2 and CNS distribution. Estimated human dose range; 2-20 mg twice daily.

12 Other therapeutic potential for PN6047? Anxiety and depression Some other selective DOR agonists (e.g. SNC80, NIH11082, UFP512, ADL5859) are antidepressant and anxiolytic in preclinical models comparable to SSRIs and TCAs. Neuroprotection DOR antagonism prevents neurodegeneration in the retina induced by elevation of intraocular pressure. Potential in Alzheimer s, Parkinson s Diseases. 12

13 In summary Why is PN6047 potentially important? Can be a safe and effective treatment for chronic pain. Large patient populations. Great potential in related CNS diseases. Lacks side effects (a huge burden for morphinelike opioids). PN6047 has the potential to be a first-line chronic pain medicine. 13

14 PN6047 development PharmNovo now give the opportunity for a Pharma, in a good industrial collaboration, to work with us and take PN6047 into clinical testing.

Potential for delta opioid receptor agonists as analgesics in chronic pain therapy

Potential for delta opioid receptor agonists as analgesics in chronic pain therapy Potential for delta opioid receptor agonists as analgesics in chronic pain therapy David Kendall & Bengt von Mentzer; PharmNovo AB/UK Alex Conibear & Eamonn Kelly, University of Bristol Junaid Asghar,

More information

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015 Analgesia for Patients with Substance Abuse Disorders Lisa Jennings CN November 2015 Definitions n Addiction: A pattern of drug use characterised by aberrant drug-taking behaviours & the compulsive use

More information

Acute Pain NETP: SEPTEMBER 2013 COHORT

Acute Pain NETP: SEPTEMBER 2013 COHORT Acute Pain NETP: SEPTEMBER 2013 COHORT Pain & Suffering an unpleasant sensory & emotional experience associated with actual or potential tissue damage, or described in terms of such damage International

More information

BEHAVIOURAL SCREENING OF DRUGS HYPNOTICS/SEDATIVES

BEHAVIOURAL SCREENING OF DRUGS HYPNOTICS/SEDATIVES BEHAVIOURAL SCREENING OF DRUGS I. PHARMACOLOGICAL PROPERTIES OF SOME CNS AFFECTIVE AGENTS HYPNOTICS/SEDATIVES The hypnotics and sedatives are one of the most widely prescribed classes of drugs on the market.

More information

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls Opioids, Overdose, and Fentanyls Outline: What are opioids? Why are we experiencing and opioid crisis? Potency, purity, and product How do opioids cause overdose and overdose deaths? What is naloxone and

More information

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA Pharmacogenetics of Codeine Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA 1 Codeine Overview Naturally occurring opium alkaloid Demethylated to morphine for analgesic effect

More information

Opioid Pharmacology. Dr Ian Paterson, MA (Pharmacology), MB BS, FRCA, MAcadMEd. Consultant Anaesthetist Sheffield Teaching Hospitals

Opioid Pharmacology. Dr Ian Paterson, MA (Pharmacology), MB BS, FRCA, MAcadMEd. Consultant Anaesthetist Sheffield Teaching Hospitals Opioid Pharmacology Dr Ian Paterson, MA (Pharmacology), MB BS, FRCA, MAcadMEd Consultant Anaesthetist Sheffield Teaching Hospitals Introduction The available opioids and routes of administration - oral

More information

Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer

Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I Mr.D.Raju,M.pharm, Lecturer Mechanisms of Pain and Nociception Nociception is the mechanism whereby noxious peripheral stimuli are transmitted to

More information

6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages

6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages Nalbuphine: Analgesic with a Niche Mellar P Davis MD FCCP FAAHPM 1 Summary of Advantages Safe in renal failure- fecal excretion Analgesia equal to morphine with fewer side effects Reduced constipation

More information

Fentanyls and Naloxone. Opioids, Overdose, and Naloxone

Fentanyls and Naloxone. Opioids, Overdose, and Naloxone Opioids, Overdose, and Naloxone Presenter Disclosure Presenter s Name: Michael Beazely I have no current or past relationships with commercial entities Speaking Fees for current program: I have received

More information

Choose a category. You will be given the answer. You must give the correct question. Click to begin.

Choose a category. You will be given the answer. You must give the correct question. Click to begin. Instructions for using this template. Remember this is Jeopardy, so where I have written Answer this is the prompt the students will see, and where I have Question should be the student s response. To

More information

What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls?

What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls? What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls? What is an opioid? What do opioids do?: The term opioid can be

More information

Understanding pain and mental illness Impact on management principles

Understanding pain and mental illness Impact on management principles Understanding pain and mental illness Impact on management principles Chris Alderman Consultant Psychopharmacologist Pain and mental illness - context PAIN MENTAL ILLNESS OTHER FACTORS (personality, history.

More information

OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4

OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4 Opioid MCQ OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4 OP02 [Mar96] Which factor does NOT predispose to bradycardia with

More information

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid Definition All drugs, natural or synthetic, that bind to opiate receptors Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid agonists increase pain threshold

More information

OST. Pharmacology & Therapeutics. Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO

OST. Pharmacology & Therapeutics. Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO OST Pharmacology & Therapeutics Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO Disclaimer In the past two years I have received no payment for services from any agency other than government or academic.

More information

IK01400: non-opioid preclinical drug candidate for pain treatment

IK01400: non-opioid preclinical drug candidate for pain treatment IK01400: non-opioid preclinical drug candidate for pain treatment Introduction Bio-Link presents a valuable licensing opportunity for the development of novel nonopioid drug candidates to manage acute

More information

Drugs Used In Management Of Pain. Dr. Aliah Alshanwani

Drugs Used In Management Of Pain. Dr. Aliah Alshanwani Drugs Used In Management Of Pain Dr. Aliah Alshanwani 1 Drugs Used In Management Of Pain A CASE OF OVERDOSE Sigmund Freud, the father of psychoanalysis His cancer of the jaw was causing him increasingly

More information

Action Potentials and Synaptic Transmission. BIO 219 Napa Valley College Dr. Adam Ross

Action Potentials and Synaptic Transmission. BIO 219 Napa Valley College Dr. Adam Ross Action Potentials and Synaptic Transmission BIO 219 Napa Valley College Dr. Adam Ross Review of action potentials Nodes of Ranvier Nucleus Dendrites Cell body In saltatory conduction, the nerve impulses

More information

BJF Acute Pain Team Formulary Group

BJF Acute Pain Team Formulary Group Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution

More information

5 A s Opioid therapy monitoring tool

5 A s Opioid therapy monitoring tool 5 A s Opioid therapy monitoring tool Once initiating opioid therapy, it should be monitored regularly by assessing what has been called the 5As of Analgesia therapy. This monitoring tool, will assist you

More information

PAIN. Physiology of pain relating to pain management

PAIN. Physiology of pain relating to pain management PAIN Physiology of pain relating to pain management What is pain? An unpleasant sensory and emotional experience associated with actual or potential tissue damage. (Melzac and Wall) The generation of pain

More information

Abbott s TRPV1 Antagonist Program

Abbott s TRPV1 Antagonist Program Abbott s TRPV1 Antagonist Program Connie R. Faltynek, Ph.D. Sr. Director, Neuroscience and Pain Discovery American Pain Society Annual Meeting Basic Science Dinner Symposium May 9, 2008 Early History of

More information

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory Opioids: Use, Abuse and Cause of Death Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory jharmon@occl.ocgov.com Opioid: Any psychoactive chemical that resembles morphine

More information

CHAMP: Bedside Teaching TREATING PAIN. Stacie Levine MD. What is the approach to treating pain in the aging adult patient?

CHAMP: Bedside Teaching TREATING PAIN. Stacie Levine MD. What is the approach to treating pain in the aging adult patient? CHAMP: Bedside Teaching TREATING PAIN Stacie Levine MD Teaching Trigger: An older adult patient is identified as having pain. Clinical Question: What is the approach to treating pain in the aging adult

More information

Cannabis. Member of the Cannabaceae family of flowering plants (along with hops) Cannabis sativa (v. sativa, indica, afghanica, ruderalis)

Cannabis. Member of the Cannabaceae family of flowering plants (along with hops) Cannabis sativa (v. sativa, indica, afghanica, ruderalis) Member of the Cannabaceae family of flowering plants (along with hops) sativa (v. sativa, indica, afghanica, ruderalis) Only females flowers contain high concentrations of psychoactive oils (cannabinoids)

More information

Nociceptive Pain. Pathophysiologic Pain. Types of Pain. At Presentation. At Presentation. Nonpharmacologic Therapy. Modulation

Nociceptive Pain. Pathophysiologic Pain. Types of Pain. At Presentation. At Presentation. Nonpharmacologic Therapy. Modulation Learning Objectives Effective, Safe Analgesia An Approach to Appropriate Outpatient Chronic Pain Treatment By the end of this presentation, participants will be able to: Identify multiple factors that

More information

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA www.ivis.org Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct. 14-17, 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA http://www.ivis.org 14(Fri)

More information

Pain and its Treatments. Our Goals: Understand: What is pain and what causes it? 2. What are different types of pain? 3. How do opioid drugs work?

Pain and its Treatments. Our Goals: Understand: What is pain and what causes it? 2. What are different types of pain? 3. How do opioid drugs work? Pain and its Treatments Cheryl Stucky, Ph.D. Medical College of Wisconsin Our Goals: Understand: 1. What is pain and what causes it? 2. What are different types of pain? 3. How do opioid drugs work? What

More information

UCSF Pediatric Hospital Medicine Boot Camp Pain Session 6/21/14. Cynthia Kim and Stephen Wilson

UCSF Pediatric Hospital Medicine Boot Camp Pain Session 6/21/14. Cynthia Kim and Stephen Wilson UCSF Pediatric Hospital Medicine Boot Camp Pain Session 6/21/14 Cynthia Kim and Stephen Wilson Rules Buzz first and player answers If answer correct, then the player asks teammates if they want to keep

More information

Shift 1, 8 July 2018, 09:30-13:00

Shift 1, 8 July 2018, 09:30-13:00 Shift 1, 8 July 2018, 09:30-13:00 CNS patterning A001-A014 Stem cells: basic biology and postnatal neurogenesis - part I Development of neural systems: Molecular and genetic characterisationa Epigenetic

More information

Tramadol has an affinity for m opiate receptors of 10 times less than that of codeine and 6000 times less than morphine( [ii] ).

Tramadol has an affinity for m opiate receptors of 10 times less than that of codeine and 6000 times less than morphine( [ii] ). (Ultram, Zydol, Tramake) Tramadol is a centrally-acting analgesic agent which has a weak opiate agonist action but also inhibits norepinephrine reuptake and stimulates the release of serotonin( [i] ).

More information

BELLUS Health and NEOMED Institute Transaction Licensing of BLU-5937 for Chronic Cough

BELLUS Health and NEOMED Institute Transaction Licensing of BLU-5937 for Chronic Cough BELLUS Health and NEOMED Institute Transaction Licensing of BLU-5937 for Chronic Cough February 28, 2017 r Investment Thesis BLU-5937: potential to be best-in-class drug addressing high unmet need Orally

More information

Narcotic Analgesics. Jacqueline Morgan March 22, 2017

Narcotic Analgesics. Jacqueline Morgan March 22, 2017 Narcotic Analgesics Jacqueline Morgan March 22, 2017 Pain Unpleasant sensory and emotional experience with actual or potential tissue damage Universal, complex, subjective experience Number one reason

More information

PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST

PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST TREATMENT IN ONCOLOGY Main treatment : surgery Neoadjuvant treatment : RT, CMT Adjuvant treatment : Tx micrometastatic disease -CMT,Targeted

More information

CHAPTER 4 PAIN AND ITS MANAGEMENT

CHAPTER 4 PAIN AND ITS MANAGEMENT CHAPTER 4 PAIN AND ITS MANAGEMENT Pain Definition: An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Types of Pain

More information

Medications for the Treatment of Neuropathic Pain

Medications for the Treatment of Neuropathic Pain Medications for the Treatment of Neuropathic Pain February 23, 2011 Jinny Tavee, MD Associate Professor Neurological Institute Cleveland Clinic Foundation Neuropathic Pain Pain, paresthesias, and sensory

More information

PART 1.B SPC, LABELLING AND PACKAGE LEAFLET

PART 1.B SPC, LABELLING AND PACKAGE LEAFLET TRAMADOG, solution for injection Decentralised Procedure D195 February 2018 V3 Tramadol HCl 50 mg/ml Part 1.B SPC, Labelling and Package Leaflet PART 1.B SPC, LABELLING AND PACKAGE LEAFLET 1B- 1 ANNEX

More information

Q&A: Opioid Prescribing for Chronic Non-Malignant Pain

Q&A: Opioid Prescribing for Chronic Non-Malignant Pain NHS Hastings and Rother Clinical Commissioning Group Chair Dr David Warden Chief Officer Amanda Philpott NHS Eastbourne, Hailsham and Seaford Clinical Commissioning Group Chair Dr Martin Writer Chief Officer

More information

CONTENTS. Disclosure of Conflict of Interest. None. Is opioid effective in long-term use? Can opioid exacerbate pain? Why are we still using opioids?

CONTENTS. Disclosure of Conflict of Interest. None. Is opioid effective in long-term use? Can opioid exacerbate pain? Why are we still using opioids? Why Are We Still Using Opioids If Opioid Therapy Are So Problematic? Jianren Mao, MD, PhD Richard J. Kitz Professor of Anesthesia Research Harvard Medical School, Harvard University Vice Chair for Research

More information

Prescription Pain Management. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D

Prescription Pain Management. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D Prescription Pain Management University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D 2 Objectives Understand how to preform a pain assessment Know which medications

More information

Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008

Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008 Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008 PAIN MECHANISMS Somatic Nociceptive Visceral Inflammatory response sensitizes

More information

IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE?

IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE? NON-OPIOID TREATMENT OPTIONS FOR CHRONIC PAIN Alison Knutson, PharmD, BCACP Medication Management Pharmacist Park Nicollet Creekside Clinic Dr. Knutson indicated no potential conflict of interest to this

More information

Receptors and Neurotransmitters: It Sounds Greek to Me. Agenda. What We Know About Pain 9/7/2012

Receptors and Neurotransmitters: It Sounds Greek to Me. Agenda. What We Know About Pain 9/7/2012 Receptors and Neurotransmitters: It Sounds Greek to Me Cathy Carlson, PhD, RN Northern Illinois University Agenda We will be going through this lecture on basic pain physiology using analogies, mnemonics,

More information

Part IV: Nursing Assistant Roles in Observing and Relieving Pain

Part IV: Nursing Assistant Roles in Observing and Relieving Pain Part IV: Nursing Assistant Roles in Observing and Relieving Pain Objectives: Describe the roles of the NA in EOL care and pain management Define pain Describe acute and chronic pain Describe some common

More information

Lehman Brothers Eighth Annual Global Healthcare Conference March 30, 2005 Bruce A. Peacock President and Chief Executive Officer

Lehman Brothers Eighth Annual Global Healthcare Conference March 30, 2005 Bruce A. Peacock President and Chief Executive Officer Lehman Brothers Eighth Annual Global Healthcare Conference March 30, 2005 Bruce A. Peacock President and Chief Executive Officer 2005 Adolor Corporation. All rights reserved. Safe Harbor Statement This

More information

2018 Learning Outcomes

2018 Learning Outcomes I. Pain Physiology and Anatomy (20%) A. Describe the basic anatomy of the nervous system. B. Describe the physiological mechanisms of neuronal function (eg- action potentials). C. Review the nociceptive

More information

Modulation of TRP channels by resolvins in mouse and human

Modulation of TRP channels by resolvins in mouse and human July 9, 2015, Ion Channel Retreat, Vancouver Ion Channel and Pain Targets Modulation of TRP channels by resolvins in mouse and human Ru-Rong Ji, PhD Pain Research Division Department of Anesthesiology

More information

The study of drugs. Pharmacology

The study of drugs. Pharmacology The study of drugs Pharmacology Psychopharmacology The study of psychoactive drugs Psychoactive drugs Drugs that influence psychological processes mood emotion perception cognition behavior Psychoactive

More information

Long term pharmacotherapy for Alcohol Dependence: Anti Craving agents

Long term pharmacotherapy for Alcohol Dependence: Anti Craving agents Long term pharmacotherapy for Alcohol Dependence: Anti Craving agents Myth or Reality? Complete Recovery means a medication-free state True or False? Treatment of Alcoholism Assessment Motivation Alcohol

More information

Pain Management in Older Adults. Mary Shelkey, PhD, ARNP

Pain Management in Older Adults. Mary Shelkey, PhD, ARNP Pain Management in Older Adults Mary Shelkey, PhD, ARNP Cause of Death/ Demographic and Social Trends Early 1900s Current Medicine's Focus Comfort Cure Cause of Death Infectious Diseases/ Communicable

More information

NEWER OPTIONS FOR CHRONIC PAIN MANAGEMENT

NEWER OPTIONS FOR CHRONIC PAIN MANAGEMENT NEWER OPTIONS FOR CHRONIC PAIN MANAGEMENT Robert M. Stein, DVM, DAAPM President, IVAPM Animal Pain Management Center Founder/Webmaster www.vasg.org VIN Anesthesia/Analgesia Consultant Editor Chronic pain

More information

THE OPIUM POPPY OPIOID PHARMACOLOGY 2/18/16. PCTH 300/305 Andrew Horne, PhD MEDC 309. Papaver somniferum. Poppy Seeds Opiates

THE OPIUM POPPY OPIOID PHARMACOLOGY 2/18/16. PCTH 300/305 Andrew Horne, PhD MEDC 309. Papaver somniferum. Poppy Seeds Opiates OPIOID PHARMACOLOGY PCTH 300/305 Andrew Horne, PhD andrew.horne@ubc.ca MEDC 309 THE OPIUM POPPY Papaver somniferum Sleep-bringing poppy Poppy Seeds Opiates Opium Poppy Straw 1 OPIATES VS. OPIOIDS Opiates:

More information

Analgesic-Sedatives Drug Dose Onset

Analgesic-Sedatives Drug Dose Onset Table 4. Commonly used medications in procedural sedation and analgesia Analgesic-Sedatives Fentanyl Morphine IV: 1-2 mcg/kg Titrate 1 mcg/kg q3-5 minutes prn IN: 2 mcg/kg Nebulized: 3 mcg/kg IV: 0.05-0.15

More information

Non Malignant Pain: Symptom Management

Non Malignant Pain: Symptom Management Non Malignant Pain: Symptom Management Renal Care Symposium July 2018 Anica Vasic Pain Management Unit St George Hospital Definitions Prevalence Assessment Treatment Medications Newer agents: tapentadol,

More information

MANAGEMENT OF DIABETIC NEUROPATHY. Chungnam University Hospital Soo-Kyung, Bok, M.D., Ph.D.

MANAGEMENT OF DIABETIC NEUROPATHY. Chungnam University Hospital Soo-Kyung, Bok, M.D., Ph.D. MANAGEMENT OF DIABETIC NEUROPATHY Chungnam University Hospital Soo-Kyung, Bok, M.D., Ph.D. The Diabetic neuropathy cannot be reversed Not to restore function to damaged nerve Slowly progress no initial

More information

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment This booklet was created to help you learn about tapering. You probably have lots

More information

Inpatient Management of Trauma Related Pain

Inpatient Management of Trauma Related Pain Inpatient Management of Trauma Related Pain STOMP Summit September 9, 2016 Ann O Rourke, MD, MPH University of Wisconsin Department of Surgery 1 Our patient Small SDH Intubated Hemopneumothorax with multiple

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tralieve 50 mg/ml solution for injection for dogs (AT, BE, BG, CY, CZ, DE, EL, ES, HR, HU, IE, IT, LU, NL, PT, RO,

More information

Potential Best-In-Class Potent, Selective & Orally Active S1P 1 Agonists for Multiple Sclerosis

Potential Best-In-Class Potent, Selective & Orally Active S1P 1 Agonists for Multiple Sclerosis Potential Best-In-Class Potent, Selective & Orally Active S1P 1 Agonists for Multiple Sclerosis Art Taveras, PhD March 25, 2009 Therapeutic Hypothesis of S1P Agonism Multiple Sclerosis (MS): A chronic

More information

OPIOIDS AND NON-CANCER PAIN

OPIOIDS AND NON-CANCER PAIN Ch05.qxd 1/6/04 4:33 PM Page 77 CHAPTER 5 OPIOIDS AND NON-CANCER PAIN Background 78 Side-effects of opioids 78 Tolerance, physical dependence and addiction 79 Opioid-induced pain 79 Practical issues 80

More information

Interaction between Sedation and Weaning: How to Balance Them? Guillermo Castorena MD Fundacion Clinica Medica Sur Mexico

Interaction between Sedation and Weaning: How to Balance Them? Guillermo Castorena MD Fundacion Clinica Medica Sur Mexico Interaction between Sedation and Weaning: How to Balance Them? Guillermo Castorena MD Fundacion Clinica Medica Sur Mexico Balance is not that easy! Weaning Weaning is the liberation of a patient from

More information

Pain Management Management in Hepatic Hepatic and and Renal Dysfunction

Pain Management Management in Hepatic Hepatic and and Renal Dysfunction Pain Management in Hepatic and Renal Dysfunction Review the pharmacologic basis for medications used in pain management Identify pain medications which hshould ldbe avoided in patients with hepatic dysfunction

More information

A. Correct! Nociceptors are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain.

A. Correct! Nociceptors are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain. Pharmacology - Problem Drill 19: Anti-Inflammatory and Analgesic Drugs No. 1 of 10 1. are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain. #01 (A) Nociceptors (B) Histamines

More information

PAIN TERMINOLOGY TABLE

PAIN TERMINOLOGY TABLE PAIN TERMINOLOGY TABLE TERM DEFINITION HOW TO USE CLINICALLY Acute Pain Pain that is usually temporary and results from something specific, such as a surgery, an injury, or an infection Addiction A chronic

More information

Arresting Pain without Getting Arrested

Arresting Pain without Getting Arrested G. Jay Westbrook, M.S., R.N., CHPN - Clinical Director Compassionate Journey: An End-of-Life Clinical & Education Service CompassionateJourney@hotmail.com 818/773-3700 Arresting Pain without Getting Arrested

More information

How to manage severe postoperative pain? Pr Patricia Lavand homme Anesthesiology Dpt & Acute Pain Service Brussels, Belgium

How to manage severe postoperative pain? Pr Patricia Lavand homme Anesthesiology Dpt & Acute Pain Service Brussels, Belgium How to manage severe postoperative pain? Pr Patricia Lavand homme Anesthesiology Dpt & Acute Pain Service Brussels, Belgium No conflict of interest to declare. Does severe acute postoperative pain still

More information

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK GUIDELINES AND AUDIT IMPLEMENTATION NETWORK General Palliative Care Guidelines The Management of Pain at the End Of Life November 2010 Aim To provide a user friendly, evidence based guide for the management

More information

Basics of Pharmacology

Basics of Pharmacology Basics of Pharmacology Pekka Rauhala Transmed 2013 What is pharmacology? Pharmacology may be defined as the study of the effects of drugs on the function of living systems Pharmacodynamics The mechanism(s)

More information

Karam Darwish. Dr. Munir. Munir Gharaibeh

Karam Darwish. Dr. Munir. Munir Gharaibeh 7 Karam Darwish Dr. Munir Munir Gharaibeh Opioid Analgesics Pain is an important symptom as it is usually the symptom that brings the patient to the hospital, and an Analgesic is a drug used to relieve

More information

Medical Cannabinoids for the Management of Chronic Noncancer Pain

Medical Cannabinoids for the Management of Chronic Noncancer Pain Medical Cannabinoids for the Management of Chronic Noncancer Pain Dr Mark A. Ware MBBS MSc McGill University 12 June 2018 Disclosures Grants: CanniMed Consulting: CHI Inc Emmes 1 Canadian Consortium for

More information

Naltrexone for the treatment of Crohn s disease

Naltrexone for the treatment of Crohn s disease Naltrexone for the treatment of Crohn s disease DR. NILESH CHANDE COORDINATING EDITOR, IBD REVIEW GROUP; UNIVERSITY OF WESTERN ONTARIO, LONDON, ON CANADA Opioid receptors 3 major types kappa κ delta δ

More information

Theravance Announces Positive Results from Phase 1 and Phase 2 Clinical Studies with TD-1211 in Development for Opioid-Induced Constipation

Theravance Announces Positive Results from Phase 1 and Phase 2 Clinical Studies with TD-1211 in Development for Opioid-Induced Constipation Theravance Announces Positive Results from Phase 1 and Phase 2 Clinical Studies with TD-1211 in Development for Opioid-Induced Constipation TD-1211 Achieves Primary and Secondary Endpoints SOUTH SAN FRANCISCO,

More information

Opioid Induced Constipation Lisa Clince Acute Pain CNS Palmerston North Hospital

Opioid Induced Constipation Lisa Clince Acute Pain CNS Palmerston North Hospital Opioid Induced Constipation Lisa Clince Acute Pain CNS Palmerston North Hospital 21-04-2016 MidCentral District Health Board 1 Overview Patient Experience Opioid Collaborative Constipation defined Opioid

More information

Summary of Product Characteristics Part IB1 Tramadol HCl Disphar druppels 100 mg/ml, oral drops Page 1 of 7

Summary of Product Characteristics Part IB1 Tramadol HCl Disphar druppels 100 mg/ml, oral drops Page 1 of 7 Tramadol HCl Disphar druppels 100 mg/ml, oral drops Page 1 of 7 1. NAME OF THE MEDICINAL PRODUCT Tramadol HCl Disphar druppels 100 mg/ml, oral drops 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution

More information

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1) Pain - subjective experience associated with detection of tissue damage ( nociception ) acute - serves as a warning chronic - nociception gone bad often accompanied by clinical depression fibromyalgia,

More information

POST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS

POST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS POST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS November 9, 2018 Aimee LaMere, CNP Molly McNaughton, CNP Leslie Weide, MSW, LICSW, ACM Disclosures: Conflict of interest statement: We certify that,

More information

SEEING KETAMINE IN A NEW LIGHT

SEEING KETAMINE IN A NEW LIGHT SEEING KETAMINE IN A NEW LIGHT BobbieJean Sweitzer, M.D., FACP Professor of Anesthesiology Director of Perioperative Medicine Northwestern University Bobbie.Sweitzer@northwestern.edu LEARNING OBJECTIVES

More information

ANNEX III LABELLING AND PACKAGE LEAFLET

ANNEX III LABELLING AND PACKAGE LEAFLET ANNEX III LABELLING AND PACKAGE LEAFLET 1 A. LABELLING 2 PARTICULARS TO APPEAR ON THE OUTER PACKAGE AND THE IMMEDIATE PACKAGE Outer carton Multi-pack 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tralieve

More information

Pain Management Strategies Webinar/Teleconference

Pain Management Strategies Webinar/Teleconference Pain Management Strategies Webinar/Teleconference Barry K. Baines, MD April 16, 2009 Objectives Describe the principles of pain management. Identify considerations in the use of opioids. Describe the benefits

More information

Neuropathic Pain in Palliative Care

Neuropathic Pain in Palliative Care Neuropathic Pain in Palliative Care Neuropathic Pain in Advanced Cancer Affects 40% of patients Multiple concurrent pains are common Often complex pathophysiology with mixed components Nocioceptive Neuropathic

More information

Spinal Cord Injury Pain. Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018

Spinal Cord Injury Pain. Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018 Spinal Cord Injury Pain Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018 Objectives At the conclusion of this session, participants should be able to: 1. Understand the difference between nociceptive

More information

TRANSCUTANEOUS ELECTRICAL STIMULATION

TRANSCUTANEOUS ELECTRICAL STIMULATION TRANSCUTANEOUS ELECTRICAL STIMULATION Transcutaneous electrical stimulation (TENS) Transcutaneous electrical stimulation ; An electronic device that produces electrical signals used to stimulate nerve

More information

10/08/59 PAIN IS THE MOST COMMON TREATABLE SYMPTOM OF CANCER CURRENT EVIDENCE BASED CONCEPTS: MANAGEMENT OF CANCER PAIN PAIN AN UNMET CLINICAL NEED IN

10/08/59 PAIN IS THE MOST COMMON TREATABLE SYMPTOM OF CANCER CURRENT EVIDENCE BASED CONCEPTS: MANAGEMENT OF CANCER PAIN PAIN AN UNMET CLINICAL NEED IN Pain is a frequent complication of cancer, and is common in many other life-limiting illnesses MANAGEMENT OF CANCER PAIN A/Prof Ghauri Aggarwal FRACP, FAChPM, FFPMANZCA Palliative Medicine Physician Sydney

More information

Overview of Pharmacodynamics. Psyc 472 Pharmacology of Psychoactive Drugs. Pharmacodynamics. Effects on Target Binding Site.

Overview of Pharmacodynamics. Psyc 472 Pharmacology of Psychoactive Drugs. Pharmacodynamics. Effects on Target Binding Site. Pharmacodynamics Overview of Pharmacodynamics Psychology 472: Pharmacology of Psychoactive Drugs Generally is defined as effects of drugs on a systems Can be associated with any system Neural, Heart, Liver,

More information

Side-effects of opioids what are they, are they common, and how do I deal with them?

Side-effects of opioids what are they, are they common, and how do I deal with them? Side-effects of opioids what are they, are they common, and how do I deal with them? Professor Derek Flaherty BVMS, DVA, DipECVAA, MRCA, MRCVS RCVS and European Specialist in Veterinary Anaesthesia Opioid

More information

The Opportunity: Parkinson s disease, RLS, ADHD, and disease modification YKP10461

The Opportunity: Parkinson s disease, RLS, ADHD, and disease modification YKP10461 The Opportunity: Parkinson s disease, RLS, ADHD, and disease modification YKP10461 1 TABLE OF CONTENTS Profile Summary Mechanism of Action Clinical Study Results Pharmacologic Profile Safety and Toxicity

More information

Using methadone alongside other opioids. Dr. Jo Murrell BVSc. (hons), PhD, DiplECVAA, MRCVS

Using methadone alongside other opioids. Dr. Jo Murrell BVSc. (hons), PhD, DiplECVAA, MRCVS Using methadone alongside other opioids Dr. Jo Murrell BVSc. (hons), PhD, DiplECVAA, MRCVS Why might we want to use methadone alongside other opioids? 1. Multi-modal analgesia strategies e.g. using methadone

More information

Cannabinoids and Mental Health

Cannabinoids and Mental Health Cannabinoids and Mental Health https://upload.wikimedia.org/wikipedia/commons Karen M. Lounsbury, PhD Professor of Pharmacology 802-656-3231, Karen.lounsbury@uvm.edu Objectives Describe the underlying

More information

Guidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP).

Guidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP). Surrey (East Surrey CCG, Guildford & Waverley CCG, North West Surrey CCG, Surrey Downs CCG & Surrey Heath CCG) North East Hampshire & Farnham CCG and Crawley, Horsham & Mid-Sussex CCG Guidelines for the

More information

Berkshire West Area Prescribing Committee Guidance

Berkshire West Area Prescribing Committee Guidance Guideline Name Berkshire West Area Prescribing Committee Guidance Date of Issue: September 2015 Review Date: September 2017 Date taken to APC: 2 nd September 2015 Date Ratified by GP MOC: Guidelines for

More information

SCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults

SCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults SCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults BACKGROUND The justification for developing these guidelines lies

More information

Disclosure. Objectives. Houston we have a problem! The epidemic of non medical use of prescription opioids. It all started with an observation

Disclosure. Objectives. Houston we have a problem! The epidemic of non medical use of prescription opioids. It all started with an observation Houston we have a problem! The epidemic of non medical use of prescription opioids Myron Yaster, MD Professor, Department of Anesthesiology myron.yaster@childrenscolorado.org Disclosure I have participated/consutled

More information

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will

More information

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will

More information

GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline

GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline Background Persistent pain is common, affecting around five million people in the UK. For many sufferers, pain can be frustrating and disabling,

More information

Naloxone. Medical Uses. Opiate overdose. From Wikipedia, the free encyclopedia. Naloxone

Naloxone. Medical Uses. Opiate overdose. From Wikipedia, the free encyclopedia. Naloxone Naloxone From Wikipedia, the free encyclopedia Naloxone Naloxone, sold under the brandname Narcan among others, is a medication used to reverse the effects of opioids, especially in overdose. [2] Naloxone

More information

Overview of Essentials of Pain Management. Updated 11/2016

Overview of Essentials of Pain Management. Updated 11/2016 0 Overview of Essentials of Pain Management Updated 11/2016 1 Overview of Essentials of Pain Management 1. Assess pain intensity on a 0 10 scale in which 0 = no pain at all and 10 = the worst pain imaginable.

More information

Pain Module. End of Life Pain Assessment and Management

Pain Module. End of Life Pain Assessment and Management Pain Module End of Life Pain Assessment and Management Assessing pain at end of life Perform the routine pain assessment asking the typical questions e.g., location, severity, quality and so forth. Perform

More information

Essential Pain Management. CC BY NC SA: This work is licensed under a Creative Commons Attribution NonCommerical ShareAlike 3.0 License.

Essential Pain Management. CC BY NC SA: This work is licensed under a Creative Commons Attribution NonCommerical ShareAlike 3.0 License. Essential Pain Management CC BY NC S: his work is licensed under a Creative Commons ttribution NonCommerical Sharelike 3.0 License. Introduction 1.1 CC BY NC S: his work is licensed under a Creative Commons

More information